Sakai Yoshiyuki, Iwata Yoshinori, Enomoto Hirayuki, Saito Masaki, Yoh Kazunori, Ishii Akio, Takashima Tomoyuki, Aizawa Nobuhiro, Ikeda Naoto, Tanaka Hironori, Iijima Hiroko, Nishiguchi Shuhei
Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.
J Gastroenterol. 2015 Jan;50(1):109-18. doi: 10.1007/s00535-014-0950-2. Epub 2014 Mar 17.
The usefulness of branched-chain amino acid (BCAA) granules and BCAA-enriched nutrient mixtures for patients with liver cirrhosis is often reported. However, no randomized controlled studies have investigated the usefulness of these supplements in the nutritional intervention of cirrhotic patients receiving endoscopic treatment for esophageal varices.
Patients without BCAA before endoscopic treatment were divided into study 1, and those who received BCAA were divided into study 2. In study 1, 44 eligible patients were divided into a control group (n = 13), a general liquid nutrient (snack) group (n = 15), and a BCAA-enriched nutrient mixture (BCAA-EN) group (n = 16). In study 2, 48 eligible patients were divided into a BCAA group (n = 24) and a BCAA-EN group (n = 24). The nutritional status including non-protein respiratory quotient (NPRQ) levels, weight gain, and albumin were evaluated on days 0, 7, and 50.
In study 1, the BCAA-EN group showed significant improvement in NPRQ levels on day 7 as compared with the snack group. In study 2, the BCAA-EN group showed significant improvement in NPRQ levels on day 7 and in weight levels on day 50 relative to the BCAA group, while the BCAA group showed improved serum albumin levels on day 7 compared to the BCAA-EN group.
The BCAA-enriched nutrient mixture maintained NPRQ and weight in cirrhotic patients. Our findings suggest that supplements including both BCAA and a nutritional energy supplement would be beneficial for cirrhotic patients undergoing endoscopic treatment for esophageal varices.
经常有报道称支链氨基酸(BCAA)颗粒和富含BCAA的营养混合物对肝硬化患者有用。然而,尚无随机对照研究调查这些补充剂在接受内镜治疗食管静脉曲张的肝硬化患者营养干预中的作用。
内镜治疗前未使用BCAA的患者分为研究1组,使用BCAA的患者分为研究2组。在研究1组中,44例符合条件的患者分为对照组(n = 13)、普通液体营养(零食)组(n = 15)和富含BCAA的营养混合物(BCAA-EN)组(n = 16)。在研究2组中,48例符合条件的患者分为BCAA组(n = 24)和BCAA-EN组(n = 24)。在第0、7和50天评估包括非蛋白呼吸商(NPRQ)水平、体重增加和白蛋白在内的营养状况。
在研究1组中,与零食组相比,BCAA-EN组在第7天NPRQ水平有显著改善。在研究2组中,相对于BCAA组,BCAA-EN组在第7天NPRQ水平有显著改善,在第50天体重水平有显著改善,而BCAA组在第7天血清白蛋白水平比BCAA-EN组有所改善。
富含BCAA的营养混合物可维持肝硬化患者的NPRQ和体重。我们的研究结果表明,同时包含BCAA和营养能量补充剂的补充剂对接受内镜治疗食管静脉曲张的肝硬化患者有益。